Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3278580
Max Phase: Preclinical
Molecular Formula: C48H77N13O12
Molecular Weight: 1028.22
Molecule Type: Small molecule
Associated Items:
ID: ALA3278580
Max Phase: Preclinical
Molecular Formula: C48H77N13O12
Molecular Weight: 1028.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)CC
Standard InChI: InChI=1S/C48H77N13O12/c1-8-26(5)38(60-41(67)31-18-19-37(64)55-31)46(72)54-28(7)40(66)59-35(24-62)44(70)58-34(23-29-14-16-30(63)17-15-29)42(68)53-27(6)39(65)57-33(22-25(3)4)43(69)56-32(12-10-20-52-48(49)50)47(73)61-21-11-13-36(61)45(71)51-9-2/h14-17,25-28,31-36,38,62-63H,8-13,18-24H2,1-7H3,(H,51,71)(H,53,68)(H,54,72)(H,55,64)(H,56,69)(H,57,65)(H,58,70)(H,59,66)(H,60,67)(H4,49,50,52)/t26-,27+,28-,31-,32-,33-,34-,35-,36-,38-/m0/s1
Standard InChI Key: AKKFSKOBWJUSQH-QNHAFJONSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1028.22 | Molecular Weight (Monoisotopic): 1027.5815 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Humphries J, Wan YP, Folkers K.. (1977) Inhibition of the activity of the luteinizing hormone-releasing hormone (LH-RH) by analogues with variations at positions 2, 3, and 6 and the carboxyl terminus., 20 (7): [PMID:327068] [10.1021/jm00217a024] |
Source(1):